Home › Pancreatitis › NCT07447687
Soy Tomato Juice to Improve Outcomes in Pancreatitis
Soy Tomato Juice to Improve Outcomes in Pancreatitis (the STOP Trial): a Phase 1/2 Single Arm Trial
Who can join
Ages 18 to 80 · All sexes
Full eligibility criteria
Inclusion Criteria: * Diagnosis of definite chronic pancreatitis (CP) or recurrent acute pancreatitis (RAP) * Patients should be able to fully understand and participate in all aspects of the study Exclusion Criteria: * Episode of acute pancreatitis, hospitalization, or endoscopic/surgical intervention within 30 days of enrollment * Chronic, daily use of systemic immunomodulatory medication for any indication * Previous allergic reaction to soy or tomato products * Known pregnancy
About the study
This goal of this clinical trial is to see if people with recurrent acute pancreatitis or chronic pancreatitis can tolerate and regularly drink a tomato juice beverage. Researchers will also measure inflammation and ask participants to report how they feel. Everyone in the study will receive the tomato juice drink, and both participants and researchers will know what is being taken. The investigators expect the drink will be well tolerated, may lower inflammation, and may improve participant-reported symptoms and quality of life.
What is being tested
- Soy-tomato juice product (dietary supplement)
- Will include a soy-tomato juice product to be consumed during the 4 week intervention phase. A total of about 12 ounces (administered in two small cans) of the juice will be consumed (dietary supplement)
Sponsor: Ohio State University · Participants: 35 · Started: 2026-02
Contact the study team
- Spencer Harris · Phone: 614-293-6255
Official record on ClinicalTrials.gov — NCT07447687
Locations in the U.S.
| Ohio | The Ohio State University Wexner Medical Center, Columbus |
Conditions
From ClinicalTrials.gov, data retrieved Oct 2, 2026. Each study sets its own eligibility; the study team decides who can join.